{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T05:36:57Z","timestamp":1744695417761},"reference-count":32,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0378-6323.136828","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T08:30:09Z","timestamp":1405585809000},"page":"285","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of pemphigus: An Indian perspective"],"prefix":"10.25259","volume":"80","author":[{"given":"AmrinderJ","family":"Kanwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.136828-1","first-page":"21","volume-title":"Pemphigus in North India.J Cutan Med Surg","author":"Kanwar","year":"2006","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-2","first-page":"342","volume-title":"Pemphigus in Goa.J Indian Med Assoc","author":"Mascarenhas","year":"1994","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-3","first-page":"349","volume-title":"Incidence of pemphigus in Thrissur district, south India.Indian J Dermatol Venereol Leprol","author":"Kumar","year":"2008","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-4","first-page":"1236","volume-title":"Immunosuppressants and prednisone in pemphigus vulgaris: Therapeutic results obtained in 63 patients between 1961 and 1975.Arch Dermatol","author":"Lever","year":"1977","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-5","first-page":"199","volume-title":"Pulse therapy with dexamethasone- cyclophosphamide in pemphigus.Indian J Dermatol Venereol Leprol","author":"Pasricha","year":"1984","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-6","first-page":"371","volume-title":"Dexamethasone-cyclophosphamide pulse therapy in pemphigus.Int J Dermatol","author":"Kaur","year":"1990","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-7","first-page":"439","volume-title":"Pemphigus in India.Indian J Dermatol Venereol Leprol","author":"Kanwar","year":"2011","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-8","first-page":"321","volume-title":"Clinical and immunologic characterization in 26 Indian pemphigus patients.J Cutan Med Surg","author":"Tsuruta","year":"2013","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-9","first-page":"622","volume-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.J Am Acad Dermatol","author":"Chams-Davatchi","year":"2007","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-10","first-page":"2041","volume-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: A multicenter, randomized, placebo-controlled trial.J Invest Dermatol","author":"Beissert","year":"2010","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-11","first-page":"70","volume-title":"Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study.Indian J Dermatol Venereol Leprol","author":"Parmar","year":"2013","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-12","first-page":"821","volume-title":"Twelve-year clinico-therapeutic experience in pemphigus: A retrospective study of 54 cases.Int J Dermatol","author":"Mahajan","year":"2005","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-13","first-page":"e17","volume-title":"Efficacy and safety of rituximab treatment in Indian pemphigus patients.J Eur Acad Dermatol Venereol","author":"Kanwar","year":"2013","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-14","first-page":"1341","volume-title":"Clinical and immunological outcomes of high and low dose rituximab treatments in pemphigus patients: A randomized comparative observer blinded study.Br J Dermatol","author":"Kanwar","year":"2014","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-15","doi-asserted-by":"crossref","unstructured":"Heelan K, Al-Mohammedi F, Smith MJ, Knowles S, Lansang P, Walsh S, et al. Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol. JAMA Dermatol. 2014 [In press].","DOI":"10.1001\/jamadermatol.2013.6739"},{"key":"key-10.4103\/0378-6323.136828-16","first-page":"617","volume-title":"Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up.J Am Acad Dermatol","author":"Cianchini","year":"2012","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-17","first-page":"1200","volume-title":"Is it time to re-evaluate the treatment of pemphigus.J Drugs Dermatol?","author":"Leventhal","year":"2012","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-18","first-page":"472","volume-title":"First-line Combination Therapy with Rituximab and Corticosteroids is Effective and Safe for Pemphigus.Acta Derm Venereol","author":"Cho","year":"2014","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-19","first-page":"1064","volume-title":"Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.J Am Acad Dermatol","author":"Craythorne","year":"2011","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-20","first-page":"622","volume-title":"Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease.J Drugs Dermatol?","author":"Nigam","year":"2012","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-21","first-page":"671","volume-title":"Rituximab in pemphigus.Indian J Dermatol Venereol Leprol","author":"Kanwar","year":"2012","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-22","first-page":"600","volume-title":"Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.Int Immunopharmacol","author":"Daoud","year":"2006","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-23","first-page":"61","volume-title":"Pemphigus.Lancet","author":"Bystryn","year":"2005","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-24","first-page":"1157","volume-title":"Adjuvant triamcinolone acetonide injections in oro-pharyngeal pemphigus vulgaris.J Eur Acad Dermatol Venereol","author":"Mignogna","year":"2010","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-25","first-page":"46","volume-title":"IgG\/IgA pemphigus reactive with desmoglein 1 with additional undetermined reactivity with epidermal basement membrane zone.Indian J Dermatol Venereol Leprol","author":"Kanwar","year":"2014","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-26","first-page":"176","volume-title":"Pemphigus in pregnancy: Fetal risk.Int J Gynaecol Obstet","author":"Kanwar","year":"1993","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-27","first-page":"354","volume-title":"Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy.Dermatol Ther","author":"Braunstein","year":"2013","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-28","first-page":"739","volume-title":"Pemphigus vulgaris in pregnancy: Analysis of current data on the management and outcomes.Obstet Gynecol Surv","author":"Kardos","year":"2009","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-29","first-page":"1073","volume-title":"Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris.J Eur Acad Dermatol Venereol","author":"Ahmed","year":"2011","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-30","first-page":"485","volume-title":"Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.Pediatr Dermatol","author":"Mabrouk","year":"2011","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-31","first-page":"21","volume-title":"A current review of juvenile pemphigus vulgaris: Analysis of data on clinical outcomes.Am J Clin Dermatol","author":"Asarch","year":"2010","journal-title":""},{"key":"key-10.4103\/0378-6323.136828-32","doi-asserted-by":"crossref","unstructured":"Vinay K, Kanwar AJ, Sawatkar G U, Dogra S, Ishii N, Hashimoto T. Successful use of rituximab in the treatment of childhood and juvenile pemphigus. J Am Acad Dermatol. 2014 [In press].","DOI":"10.1016\/j.jaad.2014.05.071"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:39:43Z","timestamp":1612658383000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/treatment-of-pemphigus-an-indian-perspective\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["136828"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.136828","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}